Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Intracranial Tumor
- Sponsor
- Lund University Hospital
- Enrollment
- 150
- Locations
- 1
- Primary Endpoint
- Early prediction of treatment response based on MRI parameters.
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The main purposes with this trial is to investigate the potential of MRI with diffusion and blood volume, flow in brain to diagnose and to measure treatment effects in patients with intracranial tumors, especially gliomas and metastases in a prospective trial, to evaluate the possibilities to individually adjusted treatment in this category of patients depending on treatment outcomes measured by MRI, to perform clinical follow up in connection with MRI to evaluate a correlation and to perform testing of cognitive ability before, during, and after treatment and to investigate if given treatment causes any decrease in the patients habitual state.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 18 years or older
- •Suspected primary brain tumor, verified glioblastoma or non surgically treated metastases from solid tumor
- •Increasing MRI changes in patients with previous verified glioblastoma
- •Be able to speak Swedish without difficulties (because of the neuropsychological investigations)
- •Written informed concent
Exclusion Criteria
- •Unability to perform MRI
Outcomes
Primary Outcomes
Early prediction of treatment response based on MRI parameters.
Time Frame: Three weeks compared to baseline.
Secondary Outcomes
- Neuropsychological function.(Month 3, 12, and 18 compared to baseline)